Ethic Inc. Pfizer Inc Transaction History

Ethic Inc.

$4.8 Billion
Q1 2025

A detailed history of Ethic Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Ethic Inc. holds 643,515 shares of PFE stock, worth $15 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

643,515

Previous 449,474 43.17%

Holding current value

$15 Million

Previous $11.9 Million 36.75%

% of portfolio

0.34%

Previous 0.25%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$25.01 - $27.13 $4.85 Million - $5.26 Million	194,041 Added 43.17%	643,515 $16.3 Million
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $3.21 Million - $3.91 Million	129,381 Added 40.42%	449,474 $11.9 Million
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $1.37 Million - $1.55 Million	-49,341 Reduced 13.36%	320,093 $9.26 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $1.25 Million - $1.46 Million	49,341 Added 15.41%	369,434 $10.3 Million
Q1 2024 May 13, 2024	SELL	$25.89 - $29.73 $1.66 Million - $1.91 Million	-64,200 Reduced 16.71%	320,093 $8.88 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $306,766 - $398,455	-11,740 Reduced 2.96%	384,293 $11.1 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $1.11 Million - $1.3 Million	34,696 Added 9.6%	396,033 $13.1 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $1.13 Million - $1.31 Million	31,314 Added 9.49%	361,337 $13.3 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $4.53 Million - $5.9 Million	115,015 Added 53.49%	330,023 $13.5 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $3.93 Million - $5.13 Million	94,214 Added 78.0%	215,008 $11 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $1.82 Million - $2.22 Million	41,481 Added 52.3%	120,794 $5.29 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $1.92 Million - $2.27 Million	41,221 Added 108.21%	79,313 $4.16 Million
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $846,283 - $1.05 Million	18,498 Added 94.41%	38,092 $1.97 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $83,053 - $123,112	-2,010 Reduced 9.3%	19,594 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $99,184 - $127,411	2,527 Added 13.25%	21,604 $929,000
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $29,123 - $32,991	811 Added 4.44%	19,077 $747,000
Q1 2021 May 13, 2021	SELL	$33.49 - $37.77 $59,042 - $66,588	-1,763 Reduced 8.8%	18,266 $662,000
Q4 2020 Feb 10, 2021	BUY	$33.47 - $42.56 $26,876 - $34,175	803 Added 4.18%	20,029 $737,000
Q3 2020 Oct 27, 2020	BUY	$31.75 - $37.25 $357,854 - $419,844	11,271 Added 141.68%	19,226 $706,000
Q2 2020 Aug 12, 2020	BUY	$30.12 - $36.54 $2,620 - $3,178	87 Added 1.11%	7,955 $260,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $259,014 - $293,948	7,868 New	7,868 $308,000

Others Institutions Holding PFE

# of Institutions

3,369

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $131B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ethic Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ethic Inc. with notifications on news.

Account